allergic reaction, fatigue, diarrhea, hair loss, nail changes and anorexia. The approved dosing regimen for the management of prostate cancer with docetaxel is 75 mg per square metre of body ...

Reported adverse effects of docetaxel include hypersensitivity reactions (presenting as flushing, skin reactions, hypotension and bronchospasm), bone marrow suppression (neutropenia, thrombocytopenia, ...

Docetaxel is a chemotherapy drug that is used ... neutropenia, allergic reaction, fluid retention, edema, dizziness, hair loss, diarrhea, cramping and dysphagia, compared with those who took ...

For each patient, the investigators read the nursing note to look for evidence of any documented adverse effect that occurred after beginning docetaxel or paclitaxel infusion. Because of the high ...

Fluid retention and hypersensitivity reactions were infrequent and mild. The combination of docetaxel and cisplatin is effective and feasible in patients with metastatic urothelial cancer with a ...

4 patients with advanced non-small-cell lung cancer (NSCLC) treated with docetaxel developed life-threatening pneumonitis requiring mechanical ventilation. Docetaxel (30–60 mg m –2 ...

Reverse transcription polymerase chain reaction results showed that a short docetaxel treatment induced a modest increase in the expression of CYP1B1 mRNA in MDA 453 and BT-20 cells, suggesting ...